Clinical trial
Drug-Drug Interaction Study of MRA in Patient With Rheumatoid Arthritis (RA)
NCT00144560 · Chugai Pharmaceutical, Industry · Completed
Key facts
| NCT number | NCT00144560 |
|---|---|
| Title | Drug-Drug Interaction Study of MRA in Patient With Rheumatoid Arthritis (RA) |
| Official title | An Open-Label, Clinical Pharmacology Study to Investigate Drug-Drug Interaction in Patients With RA |
| Lead sponsor | Chugai Pharmaceutical, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Drug |
| Interventions | MRA(Tocilizumab) |
| Enrollment | 31 |
| Start date | Feb 1, 2005 |
| Primary completion | Aug 1, 2005 |
| Completion | Aug 1, 2005 |
| First posted | Sep 5, 2005 |
| Last update posted | Dec 15, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: